Phase II trial of weekly or bi-weekly tocilizumab with ipilimumab and nivolumab in advanced melanoma: Clinical outcomes and biomarker analysis
Anouti, Bilal, McVay, Krysta, Abraham, Manjusha, Johnson, Daniel H., Amaria, Rodabe Navroze, Spillson, Christine, Glitza, Isabella Claudia, Patel, Sapna Pradyuman, Wong, Michael K.K., McQuade, Jennifer Leigh, Tawbi, Hussein A., Davies, Michael A., Ikeguchi, Alexandra, Bentebibel, Salah-Eddine, Abdel-Wahab, Reham, Elsayes, Khaled M., Allison, James Patrick, Sharma, Padmanee, Abdel-Wahab, Noha, Diab, Adi
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Metabolic complete responses (mCR) in patients with metastatic uveal melanoma (mUM) treated with image-guided injection (IGI) of PV-10
McVay, Krysta, Sheth, Rahul, Murthy, Ravi, Gombos, Dan S., Carter, Brett W., Bhosale, Priya, Tahon, Nourel hoda, Balmes, Gener C, Coz, Ysabell M, Washington, Edwina, Rodrigues, Dominic, Wachter, Eric Andrew, Patel, Sapna Pradyuman
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article